SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316
http://www.w3.org/2000/01/rdf-schema#comment
"point mutations in Abl that rendered Bcr-Abl imatinib mesylate-resistant including a mutation that destabilized the inactive conformation of Abl suggesting that the inhibitor required inactivation of the kinase prior to binding."
xsd:string
http://purl.uniprot.org/uniprot/#_4882921F3B796483B262E708C6DAABDEE119005DD1148AFDAE7E30AEB56865EBC4974D7D1F09B0542FDD64DA1A515D1D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316
http://purl.uniprot.org/uniprot/Q3B836
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316
http://purl.uniprot.org/uniprot/#_Q3B836-mappedCitation-12393636
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1D4F514B8011FC2FE9E299DEA82E41E095AEA48B1AFE3F9D133156FA94D32B7E19FB5B5CCFF555EB12A1534B128E7316